発リンクチェック
総発リンク数：544 （重複除く：399）
外部リンク数：543 内部リンク数：1 nofollowリンク数：0
太字は外部リンク、細字は内部リンク、緑字はnofollowリンクです。
| 1 | About CTGate https://ctgate.cci.fsu.edu/about/ |
| 2 | Tutorials https://ctgate.cci.fsu.edu/tutorials/ |
| 3 | Tutorial: GIST 2.0 https://ctgate.cci.fsu.edu/tutorials/tutorial-gist-2-0/ |
| 4 | Tutorial: NHANES T2D and Ovarian Datasets https://ctgate.cci.fsu.edu/tutorials/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 5 | Tutorial: SSMD of Propensity Scores https://ctgate.cci.fsu.edu/tutorials/tutorial-ssmd-of-propensity-scores/ |
| 6 | Tutorial: Propensity Score Weighting & Matching https://ctgate.cci.fsu.edu/tutorials/tutorial-propensity-score-weighting-matching/ |
| 7 | Team Members https://ctgate.cci.fsu.edu/team-members/ |
| 8 | Related Publications https://ctgate.cci.fsu.edu/related-publication/ |
| 9 | Contact Us https://ctgate.cci.fsu.edu/contact-us/ |
| 10 | FLORIDA STATE UNIVERSITY https://fsu.edu |
| 11 | DONATE NOW https://one.fsu.edu/foundation/donate/college/communication-information/donation-form |
| 12 | College of Communication & Information https://cci.fsu.edu/ |
| 13 | School of Communication https://comm.cci.fsu.edu/ |
| 14 | School of Information https://ischool.cci.fsu.edu/ |
| 15 | School of Communication Science & Disorders https://commdisorders.cci.fsu.edu/ |
| 16 | Centers and Labs https://cci.fsu.edu/research/centers-institutes/ |
| 17 | Garnet & Gold Scholar Society https://cci.fsu.edu/scholars/ |
| 18 |
FSU Seal https://ctgate.cci.fsu.edu/ |
| 19 | CTGATE: Clinical Trial Generalizability Assessment Toolbox / |
| 20 | About CTGate https://ctgate.cci.fsu.edu/about/ |
| 21 | Tutorials https://ctgate.cci.fsu.edu/tutorials/ |
| 22 | Tutorial: GIST 2.0 https://ctgate.cci.fsu.edu/tutorials/tutorial-gist-2-0/ |
| 23 | Tutorial: NHANES T2D and Ovarian Datasets https://ctgate.cci.fsu.edu/tutorials/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 24 | Tutorial: SSMD of Propensity Scores https://ctgate.cci.fsu.edu/tutorials/tutorial-ssmd-of-propensity-scores/ |
| 25 | Tutorial: Propensity Score Weighting & Matching https://ctgate.cci.fsu.edu/tutorials/tutorial-propensity-score-weighting-matching/ |
| 26 | Team Members https://ctgate.cci.fsu.edu/team-members/ |
| 27 | Related Publications https://ctgate.cci.fsu.edu/related-publication/ |
| 28 | Contact Us https://ctgate.cci.fsu.edu/contact-us/ |
| 29 | 24926156 https://www.ncbi.nlm.nih.gov/pubmed/24926156 |
| 30 | The use of propensity scores to assess the generalizability of results from randomized trials https://ctgate.cci.fsu.edu/?page_id=219 |
| 31 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 32 | 11870014 https://www.ncbi.nlm.nih.gov/pubmed/11870014 |
| 33 | Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? https://ctgate.cci.fsu.edu/?page_id=220 |
| 34 | 12153370 https://www.ncbi.nlm.nih.gov/pubmed/12153370 |
| 35 | Representation of the elderly, women, and minorities in heart failure clinical trials https://ctgate.cci.fsu.edu/?page_id=221 |
| 36 | 14628985 https://www.ncbi.nlm.nih.gov/pubmed/14628985 |
| 37 | How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? https://ctgate.cci.fsu.edu/?page_id=222 |
| 38 | 14770052 https://www.ncbi.nlm.nih.gov/pubmed/14770052 |
| 39 | Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. https://ctgate.cci.fsu.edu/?page_id=223 |
| 40 | 15705630 https://www.ncbi.nlm.nih.gov/pubmed/15705630 |
| 41 | Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria. https://ctgate.cci.fsu.edu/?page_id=224 |
| 42 | 15876909 https://www.ncbi.nlm.nih.gov/pubmed/15876909 |
| 43 | Effect of study criteria on recruitment and generalizability of the results. https://ctgate.cci.fsu.edu/?page_id=225 |
| 44 | 16227797 https://www.ncbi.nlm.nih.gov/pubmed/16227797 |
| 45 | Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. https://ctgate.cci.fsu.edu/?page_id=226 |
| 46 | 16339480 https://www.ncbi.nlm.nih.gov/pubmed/16339480 |
| 47 | Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for eligibility in randomized controlled trials in secondary prevention of stroke. https://ctgate.cci.fsu.edu/?page_id=227 |
| 48 | 16569712 https://www.ncbi.nlm.nih.gov/pubmed/16569712 |
| 49 | Randomized Controlled Trials: Do They Have External Validity for Patients With Multiple Comorbidities? https://ctgate.cci.fsu.edu/?page_id=228 |
| 50 | 17502778 https://www.ncbi.nlm.nih.gov/pubmed/17502778 |
| 51 | Relevance of exclusion criteria in antidepressant clinical trials: A replication study. https://ctgate.cci.fsu.edu/?page_id=229 |
| 52 | 18438906 https://www.ncbi.nlm.nih.gov/pubmed/18438906 |
| 53 | Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment. https://ctgate.cci.fsu.edu/?page_id=230 |
| 54 | 18501096 https://www.ncbi.nlm.nih.gov/pubmed/18501096 |
| 55 | Restrictive eligibility limits access to newer therapies in non-small-cell lung cancer: the implications of Eastern Cooperative Oncology Group 4599 https://ctgate.cci.fsu.edu/?page_id=231 |
| 56 | 18557666 https://www.ncbi.nlm.nih.gov/pubmed/18557666 |
| 57 | Generalizability of clinical trial results for major depression to community samples: results from the National Epidemiologic Survey on Alcohol and Related Conditions. https://ctgate.cci.fsu.edu/?page_id=232 |
| 58 | 18577549 https://www.ncbi.nlm.nih.gov/pubmed/18577549 |
| 59 | Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials. https://ctgate.cci.fsu.edu/?page_id=233 |
| 60 | 18579319 https://www.ncbi.nlm.nih.gov/pubmed/18579319 |
| 61 | Generalizability of clinical trials for alcohol dependence to community samples. https://ctgate.cci.fsu.edu/?page_id=234 |
| 62 | 19057955 https://www.ncbi.nlm.nih.gov/pubmed/19057955 |
| 63 | Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial. https://ctgate.cci.fsu.edu/?page_id=235 |
| 64 | 19342462 https://www.ncbi.nlm.nih.gov/pubmed/19342462 |
| 65 | Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? https://ctgate.cci.fsu.edu/?page_id=236 |
| 66 | 20547574 https://www.ncbi.nlm.nih.gov/pubmed/20547574 |
| 67 | Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. https://ctgate.cci.fsu.edu/?page_id=237 |
| 68 | 21078225 https://www.ncbi.nlm.nih.gov/pubmed/21078225 |
| 69 | The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. https://ctgate.cci.fsu.edu/?page_id=238 |
| 70 | 22459203 https://www.ncbi.nlm.nih.gov/pubmed/22459203 |
| 71 | Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role? https://ctgate.cci.fsu.edu/?page_id=239 |
| 72 | 22495990 https://www.ncbi.nlm.nih.gov/pubmed/22495990 |
| 73 | Generalizability of clinical trial results for generalized anxiety disorder to community samples. https://ctgate.cci.fsu.edu/?page_id=240 |
| 74 | 23060323 https://www.ncbi.nlm.nih.gov/pubmed/23060323 |
| 75 | Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment. https://ctgate.cci.fsu.edu/?page_id=241 |
| 76 | 23075287 https://www.ncbi.nlm.nih.gov/pubmed/23075287 |
| 77 | External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? https://ctgate.cci.fsu.edu/?page_id=242 |
| 78 | 23137143 https://www.ncbi.nlm.nih.gov/pubmed/23137143 |
| 79 | The generalizability of psychotherapy efficacy trials in major depressive disorder: An analysis of the influence of patient selection in efficacy trials on symptom outcome in daily practice. https://ctgate.cci.fsu.edu/?page_id=243 |
| 80 | 23242482 https://www.ncbi.nlm.nih.gov/pubmed/23242482 |
| 81 | Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database. https://ctgate.cci.fsu.edu/?page_id=244 |
| 82 | 23553373 https://www.ncbi.nlm.nih.gov/pubmed/23553373 |
| 83 | The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias. https://ctgate.cci.fsu.edu/?page_id=245 |
| 84 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 85 | 23561233 https://www.ncbi.nlm.nih.gov/pubmed/23561233 |
| 86 | Generalizability of clinical trial results for bipolar disorder to community samples: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. https://ctgate.cci.fsu.edu/?page_id=246 |
| 87 | 23617533 https://www.ncbi.nlm.nih.gov/pubmed/23617533 |
| 88 | Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions. https://ctgate.cci.fsu.edu/?page_id=247 |
| 89 | 24475060 https://www.ncbi.nlm.nih.gov/pubmed/24475060 |
| 90 | The real world mental health needs of heart failure patients are not reflected by the depression randomized controlled trial evidence. https://ctgate.cci.fsu.edu/?page_id=248 |
| 91 | 24621557 https://www.ncbi.nlm.nih.gov/pubmed/24621557 |
| 92 | Why do GPs exclude patients from participating in research? An exploration of adherence to and divergence from trial criteria. https://ctgate.cci.fsu.edu/?page_id=249 |
| 93 | 25154011 https://www.ncbi.nlm.nih.gov/pubmed/25154011 |
| 94 | Are participants in pharmacological and psychotherapy treatment trials for social anxiety disorder representative of patients in real-life settings? https://ctgate.cci.fsu.edu/?page_id=250 |
| 95 | 25307417 https://www.ncbi.nlm.nih.gov/pubmed/25307417 |
| 96 | Assessing the generalizability of randomized trial results to target populations. https://ctgate.cci.fsu.edu/?page_id=251 |
| 97 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 98 | 25580674 https://www.ncbi.nlm.nih.gov/pubmed/25580674 |
| 99 | Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community samples. https://ctgate.cci.fsu.edu/?page_id=252 |
| 100 | 26747392 https://www.ncbi.nlm.nih.gov/pubmed/26747392 |
| 101 | Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified? https://ctgate.cci.fsu.edu/?page_id=253 |
| 102 | 26866293 https://www.ncbi.nlm.nih.gov/pubmed/26866293 |
| 103 | Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials. https://ctgate.cci.fsu.edu/?page_id=254 |
| 104 | 27379465 https://www.ncbi.nlm.nih.gov/pubmed/27379465 |
| 105 | Generalizability of Pharmacologic and Psychotherapy Clinical Trial Results for Posttraumatic Stress Disorder to Community Samples. https://ctgate.cci.fsu.edu/?page_id=255 |
| 106 | 27491758 https://www.ncbi.nlm.nih.gov/pubmed/27491758 |
| 107 | Generalizing Treatment Effect Estimates From Sample to Population: A Case Study in the Difficulties of Finding Sufficient Data. https://ctgate.cci.fsu.edu/?page_id=256 |
| 108 | 27663386 https://www.ncbi.nlm.nih.gov/pubmed/27663386 |
| 109 | Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. https://ctgate.cci.fsu.edu/?page_id=257 |
| 110 | 27844227 https://www.ncbi.nlm.nih.gov/pubmed/27844227 |
| 111 | A novel use of the Spine Tango registry to evaluate selection bias in patient recruitment into clinical studies: an analysis of patients participating in the Lumbar Spinal Stenosis Outcome Study (LSOS) https://ctgate.cci.fsu.edu/?page_id=258 |
| 112 | 28088058 https://www.ncbi.nlm.nih.gov/pubmed/28088058 |
| 113 | Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials? https://ctgate.cci.fsu.edu/?page_id=259 |
| 114 | 28416124 https://www.ncbi.nlm.nih.gov/pubmed/28416124 |
| 115 | Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older. https://ctgate.cci.fsu.edu/?page_id=260 |
| 116 | 28535275 https://www.ncbi.nlm.nih.gov/pubmed/28535275 |
| 117 | Transportability of trial results using inverse odds of sampling weights. https://ctgate.cci.fsu.edu/?page_id=261 |
| 118 | 29097612 https://www.ncbi.nlm.nih.gov/pubmed/29097612 |
| 119 | Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder. https://ctgate.cci.fsu.edu/?page_id=262 |
| 120 | 29462814 https://www.ncbi.nlm.nih.gov/pubmed/29462814 |
| 121 | Generalizability of Findings from a Randomized Controlled Trial of Fish Oil Supplementation for Attenuating Posttraumatic Stress Symptoms among Rescue Workers in Japan https://ctgate.cci.fsu.edu/?page_id=263 |
| 122 | 29915956 https://www.ncbi.nlm.nih.gov/pubmed/29915956 |
| 123 | Generalizability of clinical trials of advanced melanoma in the real-world, population-based setting. https://ctgate.cci.fsu.edu/?page_id=264 |
| 124 | 29936654 https://www.ncbi.nlm.nih.gov/pubmed/29936654 |
| 125 | Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent regorafenib monotherapy. https://ctgate.cci.fsu.edu/?page_id=265 |
| 126 | 30096830 https://www.ncbi.nlm.nih.gov/pubmed/30096830 |
| 127 | Inclusion and Exclusion Criteria of Clinical Trials for Insomnia. https://ctgate.cci.fsu.edu/?page_id=266 |
| 128 | 30175440 https://www.ncbi.nlm.nih.gov/pubmed/30175440 |
| 129 | Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. https://ctgate.cci.fsu.edu/?page_id=267 |
| 130 | 30218805 https://www.ncbi.nlm.nih.gov/pubmed/30218805 |
| 131 | Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial. https://ctgate.cci.fsu.edu/?page_id=268 |
| 132 | 30564154 https://www.ncbi.nlm.nih.gov/pubmed/30564154 |
| 133 | The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial https://ctgate.cci.fsu.edu/?page_id=269 |
| 134 | 4020412 https://www.ncbi.nlm.nih.gov/pubmed/4020412 |
| 135 | Selection bias in clinical trials. https://ctgate.cci.fsu.edu/?page_id=270 |
| 136 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorials/NHANES_T2D.html |
| 137 | 8690832 https://www.ncbi.nlm.nih.gov/pubmed/8690832 |
| 138 | Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study. https://ctgate.cci.fsu.edu/?page_id=271 |
| 139 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 140 | 10203081 https://www.ncbi.nlm.nih.gov/pubmed/10203081 |
| 141 | Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. https://ctgate.cci.fsu.edu/?page_id=272 |
| 142 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 143 | 10470428 https://www.ncbi.nlm.nih.gov/pubmed/10470428 |
| 144 | Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. https://ctgate.cci.fsu.edu/?page_id=273 |
| 145 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 146 | 10506672 https://www.ncbi.nlm.nih.gov/pubmed/10506672 |
| 147 | Generalizing from a controlled trial: the effects of patient preference versus randomization on the outcome of inpatient versus outpatient chronic pain management. https://ctgate.cci.fsu.edu/?page_id=274 |
| 148 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 149 | 10891631 https://www.ncbi.nlm.nih.gov/pubmed/10891631 |
| 150 | Generalizability of project MATCH: a comparison of clients enrolled to those not enrolled in the study at one aftercare site. https://ctgate.cci.fsu.edu/?page_id=275 |
| 151 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 152 | 11053697 https://www.ncbi.nlm.nih.gov/pubmed/11053697 |
| 153 | Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients? https://ctgate.cci.fsu.edu/?page_id=276 |
| 154 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 155 | 10751862 https://www.ncbi.nlm.nih.gov/pubmed/10751862 |
| 156 | Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice. https://ctgate.cci.fsu.edu/?page_id=277 |
| 157 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 158 | 11165726 https://www.ncbi.nlm.nih.gov/pubmed/11165726 |
| 159 | The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy. https://ctgate.cci.fsu.edu/?page_id=278 |
| 160 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 161 | 11434951 https://www.ncbi.nlm.nih.gov/pubmed/11434951 |
| 162 | Generalisability of clinical trials in otitis media with effusion. https://ctgate.cci.fsu.edu/?page_id=279 |
| 163 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 164 | 11470387 https://www.ncbi.nlm.nih.gov/pubmed/11470387 |
| 165 | Generalizability of trial results based on randomized versus nonrandomized allocation of OME infants to ventilation tubes or watchful waiting. https://ctgate.cci.fsu.edu/?page_id=280 |
| 166 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 167 | 11694202 https://www.ncbi.nlm.nih.gov/pubmed/11694202 |
| 168 | Generalizability of findings from a chewing tobacco cessation clinical trial. https://ctgate.cci.fsu.edu/?page_id=281 |
| 169 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 170 | 11737343 https://www.ncbi.nlm.nih.gov/pubmed/11737343 |
| 171 | How generalizable are the results of large randomized controlled trials of antiretroviral therapy? https://ctgate.cci.fsu.edu/?page_id=282 |
| 172 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 173 | 12694711 https://www.ncbi.nlm.nih.gov/pubmed/12694711 |
| 174 | External validity of a randomised clinical trial of temporomandibular disorders: analysis of the patients who refused to participate in research. https://ctgate.cci.fsu.edu/?page_id=283 |
| 175 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 176 | 12701762 https://www.ncbi.nlm.nih.gov/pubmed/12701762 |
| 177 | Representativeness of trial populations: an example from a trial of adenotonsillectomy in children. https://ctgate.cci.fsu.edu/?page_id=284 |
| 178 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 179 | 12701935 https://www.ncbi.nlm.nih.gov/pubmed/12701935 |
| 180 | Does clinical trial subject selection restrict the ability to generalize use and cost of health services to "real life" subjects? https://ctgate.cci.fsu.edu/?page_id=285 |
| 181 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 182 | 15229421 https://www.ncbi.nlm.nih.gov/pubmed/15229421 |
| 183 | Assessing clinical generalizability in sedation studies of upper GI endoscopy. https://ctgate.cci.fsu.edu/?page_id=286 |
| 184 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 185 | 15334432 https://www.ncbi.nlm.nih.gov/pubmed/15334432 |
| 186 | Differences between participants and nonparticipants in an exercise trial for adults with rheumatoid arthritis. https://ctgate.cci.fsu.edu/?page_id=287 |
| 187 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 188 | 15639683 https://www.ncbi.nlm.nih.gov/pubmed/15639683 |
| 189 | External validity of randomised controlled trials: "to whom do the results of this trial apply?". https://ctgate.cci.fsu.edu/?page_id=288 |
| 190 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 191 | 15695979 https://www.ncbi.nlm.nih.gov/pubmed/15695979 |
| 192 | Population characteristics in cervical cancer trials: search for external validity. https://ctgate.cci.fsu.edu/?page_id=289 |
| 193 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 194 | 15994721 https://www.ncbi.nlm.nih.gov/pubmed/15994721 |
| 195 | Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. https://ctgate.cci.fsu.edu/?page_id=290 |
| 196 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 197 | 16225942 https://www.ncbi.nlm.nih.gov/pubmed/16225942 |
| 198 | Selection bias of elderly patients with chronic angina referred for catheterization. https://ctgate.cci.fsu.edu/?page_id=291 |
| 199 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 200 | 16639738 https://www.ncbi.nlm.nih.gov/pubmed/16639738 |
| 201 | Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. https://ctgate.cci.fsu.edu/?page_id=292 |
| 202 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 203 | 17053977 https://www.ncbi.nlm.nih.gov/pubmed/17053977 |
| 204 | Empirical evaluation of the generalizability of the sample from the Multimodal Treatment Study of ADHD. https://ctgate.cci.fsu.edu/?page_id=293 |
| 205 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 206 | 17210880 https://www.ncbi.nlm.nih.gov/pubmed/17210880 |
| 207 | External validity of clinical trials in acute myocardial infarction. https://ctgate.cci.fsu.edu/?page_id=294 |
| 208 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 209 | 17253599 https://www.ncbi.nlm.nih.gov/pubmed/17253599 |
| 210 | External validity of ST elevation myocardial infarction trials: the Zwolle studies. https://ctgate.cci.fsu.edu/?page_id=295 |
| 211 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 212 | 17453387 https://www.ncbi.nlm.nih.gov/pubmed/17453387 |
| 213 | To whom do the results of this trial apply?" External validity of a randomized controlled trial involving 130 patients scheduled for primary total hip replacement. https://ctgate.cci.fsu.edu/?page_id=296 |
| 214 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 215 | 17896305 https://www.ncbi.nlm.nih.gov/pubmed/17896305 |
| 216 | Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. https://ctgate.cci.fsu.edu/?page_id=297 |
| 217 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 218 | 18381709 https://www.ncbi.nlm.nih.gov/pubmed/18381709 |
| 219 | Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users. https://ctgate.cci.fsu.edu/?page_id=298 |
| 220 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 221 | 18414962 https://www.ncbi.nlm.nih.gov/pubmed/18414962 |
| 222 | Lifetime characteristics of participants and non-participants in a smoking cessation trial: implications for external validity and public health impact. https://ctgate.cci.fsu.edu/?page_id=299 |
| 223 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 224 | 18619799 https://www.ncbi.nlm.nih.gov/pubmed/18619799 |
| 225 | Randomized patients in IBS research had different disease characteristics compared to eligible and recruited patients. https://ctgate.cci.fsu.edu/?page_id=300 |
| 226 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 227 | 19116800 https://www.ncbi.nlm.nih.gov/pubmed/19116800 |
| 228 | Characteristics of individuals with insomnia who seek treatment in a clinical setting versus those who volunteer for a randomized controlled trial. https://ctgate.cci.fsu.edu/?page_id=301 |
| 229 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 230 | 19287330 https://www.ncbi.nlm.nih.gov/pubmed/19287330 |
| 231 | Examination of external validity in randomized controlled trials for adjuvant treatment of pancreatic adenocarcinoma. https://ctgate.cci.fsu.edu/?page_id=302 |
| 232 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 233 | 19339358 https://www.ncbi.nlm.nih.gov/pubmed/19339358 |
| 234 | Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. https://ctgate.cci.fsu.edu/?page_id=303 |
| 235 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 236 | 19556533 https://www.ncbi.nlm.nih.gov/pubmed/19556533 |
| 237 | Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: the Netherlands Stroke Survey. https://ctgate.cci.fsu.edu/?page_id=304 |
| 238 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 239 | 19631869 https://www.ncbi.nlm.nih.gov/pubmed/19631869 |
| 240 | Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. https://ctgate.cci.fsu.edu/?page_id=305 |
| 241 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 242 | 20016742 https://www.ncbi.nlm.nih.gov/pubmed/20016742 |
| 243 | Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer. https://ctgate.cci.fsu.edu/?page_id=306 |
| 244 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 245 | 20589596 https://www.ncbi.nlm.nih.gov/pubmed/20589596 |
| 246 | Trials assessing parmacotherapeutic management of aggression in psychiatric patients: comparability with clinical practice. https://ctgate.cci.fsu.edu/?page_id=307 |
| 247 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 248 | 20670761 https://www.ncbi.nlm.nih.gov/pubmed/20670761 |
| 249 | Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization. https://ctgate.cci.fsu.edu/?page_id=308 |
| 250 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 251 | 20798576 https://www.ncbi.nlm.nih.gov/pubmed/20798576 |
| 252 | Patients with borderline personality disorder not participating in an RCT: are they different? https://ctgate.cci.fsu.edu/?page_id=309 |
| 253 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 254 | 20816030 https://www.ncbi.nlm.nih.gov/pubmed/20816030 |
| 255 | Representativeness of participants in a clinical trial for attention-deficit/hyperactivity disorder? Comparison with adults from a large observational study. https://ctgate.cci.fsu.edu/?page_id=310 |
| 256 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 257 | 21059426 https://www.ncbi.nlm.nih.gov/pubmed/21059426 |
| 258 | Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome in versus not in clinical trials. https://ctgate.cci.fsu.edu/?page_id=311 |
| 259 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 260 | 21078416 https://www.ncbi.nlm.nih.gov/pubmed/21078416 |
| 261 | The generalizability of participants in Veterans Affairs Cooperative Studies Program 474, a multi-site randomized cardiac bypass surgery trial. https://ctgate.cci.fsu.edu/?page_id=312 |
| 262 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 263 | 21200334 https://www.ncbi.nlm.nih.gov/pubmed/21200334 |
| 264 | Comparison of Characteristics and Outcomes of Patients Undergoing Saphenous Vein Graft Stenting Who Were or Were Not nrolled in the Stenting of Saphenous Vein Grafts andomized Controlled Trial https://ctgate.cci.fsu.edu/?page_id=313 |
| 265 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 266 | 21325996 https://www.ncbi.nlm.nih.gov/pubmed/21325996 |
| 267 | Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients. https://ctgate.cci.fsu.edu/?page_id=314 |
| 268 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 269 | 21565848 https://www.ncbi.nlm.nih.gov/pubmed/21565848 |
| 270 | Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. https://ctgate.cci.fsu.edu/?page_id=315 |
| 271 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 272 | 21775882 https://www.ncbi.nlm.nih.gov/pubmed/21775882 |
| 273 | Cancer trials versus the real world in the United States. https://ctgate.cci.fsu.edu/?page_id=316 |
| 274 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 275 | 21956723 https://www.ncbi.nlm.nih.gov/pubmed/21956723 |
| 276 | ALS clinical trials: do enrolled patients accurately represent the ALS population? https://ctgate.cci.fsu.edu/?page_id=317 |
| 277 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 278 | 22201327 https://www.ncbi.nlm.nih.gov/pubmed/22201327 |
| 279 | Racial/ethnic differences in adults in randomized clinical trials of binge eating disorder. https://ctgate.cci.fsu.edu/?page_id=318 |
| 280 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 281 | 22316122 https://www.ncbi.nlm.nih.gov/pubmed/22316122 |
| 282 | To whom do the results of the multicenter, randomized, controlled INSECT trial (ISRCTN 24023541) apply?--assessment of external validity. https://ctgate.cci.fsu.edu/?page_id=319 |
| 283 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 284 | 22343692 https://www.ncbi.nlm.nih.gov/pubmed/22343692 |
| 285 | Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population. https://ctgate.cci.fsu.edu/?page_id=320 |
| 286 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 287 | 22371462 https://www.ncbi.nlm.nih.gov/pubmed/22371462 |
| 288 | Enrollment of extremely low birth weight infants in a clinical research study may not be representative. https://ctgate.cci.fsu.edu/?page_id=321 |
| 289 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 290 | 23092978 https://www.ncbi.nlm.nih.gov/pubmed/23092978 |
| 291 | Sampling bias in an internet treatment trial for depression. https://ctgate.cci.fsu.edu/?page_id=322 |
| 292 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 293 | 23242479 https://www.ncbi.nlm.nih.gov/pubmed/23242479 |
| 294 | The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samples. https://ctgate.cci.fsu.edu/?page_id=323 |
| 295 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 296 | 23517248 https://www.ncbi.nlm.nih.gov/pubmed/23517248 |
| 297 | Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. https://ctgate.cci.fsu.edu/?page_id=324 |
| 298 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 299 | 23633161 https://www.ncbi.nlm.nih.gov/pubmed/23633161 |
| 300 | Generalizability in the family-to-family education program randomized waitlist-control trial. https://ctgate.cci.fsu.edu/?page_id=325 |
| 301 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 302 | 23674318 https://www.ncbi.nlm.nih.gov/pubmed/23674318 |
| 303 | Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? https://ctgate.cci.fsu.edu/?page_id=326 |
| 304 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 305 | 23845385 https://www.ncbi.nlm.nih.gov/pubmed/23845385 |
| 306 | Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: contrasting LiTMUS baseline data with pre-existing placebo controlled trials. https://ctgate.cci.fsu.edu/?page_id=327 |
| 307 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 308 | 24594552 https://www.ncbi.nlm.nih.gov/pubmed/24594552 |
| 309 | Representativeness of RELAX-AHF clinical trial population in acute heart failure. https://ctgate.cci.fsu.edu/?page_id=328 |
| 310 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 311 | 24627277 https://www.ncbi.nlm.nih.gov/pubmed/24627277 |
| 312 | In and out, good and bad news, of generalizability of SWOG treatment trial results. https://ctgate.cci.fsu.edu/?page_id=329 |
| 313 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 314 | 24632781 https://www.ncbi.nlm.nih.gov/pubmed/24632781 |
| 315 | Generalizability of findings from efficacy trials for chronic depression: an analysis of eligibility criteria. https://ctgate.cci.fsu.edu/?page_id=330 |
| 316 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 317 | 24647464 https://www.ncbi.nlm.nih.gov/pubmed/24647464 |
| 318 | External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. https://ctgate.cci.fsu.edu/?page_id=331 |
| 319 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 320 | 24975869 https://www.ncbi.nlm.nih.gov/pubmed/24975869 |
| 321 | External validity of the ARISTOTLE trial in real-life atrial fibrillation patients. https://ctgate.cci.fsu.edu/?page_id=332 |
| 322 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 323 | 25024761 https://www.ncbi.nlm.nih.gov/pubmed/25024761 |
| 324 | A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records. https://ctgate.cci.fsu.edu/?page_id=333 |
| 325 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 326 | 25100338 https://www.ncbi.nlm.nih.gov/pubmed/25100338 |
| 327 | Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda. https://ctgate.cci.fsu.edu/?page_id=334 |
| 328 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 329 | 25399847 https://www.ncbi.nlm.nih.gov/pubmed/25399847 |
| 330 | Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. https://ctgate.cci.fsu.edu/?page_id=335 |
| 331 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 332 | 25427819 https://www.ncbi.nlm.nih.gov/pubmed/25427819 |
| 333 | Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study https://ctgate.cci.fsu.edu/?page_id=336 |
| 334 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 335 | 25664626 https://www.ncbi.nlm.nih.gov/pubmed/25664626 |
| 336 | Baseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study. https://ctgate.cci.fsu.edu/?page_id=337 |
| 337 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 338 | 25828873 https://www.ncbi.nlm.nih.gov/pubmed/25828873 |
| 339 | Predicting participation in psychiatric randomized controlled trials: Insights from the STEP-BD. https://ctgate.cci.fsu.edu/?page_id=338 |
| 340 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 341 | 25986472 https://www.ncbi.nlm.nih.gov/pubmed/25986472 |
| 342 | An Approach to Assess Generalizability in Comparative Effectiveness Research: A Case Study of the Whole Systems Demonstrator Cluster Randomized Trial Comparing Telehealth with Usual Care for Patients with Chronic Health Conditions. https://ctgate.cci.fsu.edu/?page_id=339 |
| 343 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 344 | 26174313 https://www.ncbi.nlm.nih.gov/pubmed/26174313 |
| 345 | Similarities and differences between patients included and excluded from a randomized clinical trial of vitamin D supplementation for improving glucose tolerance in prediabetes: interpreting broader applicability. https://ctgate.cci.fsu.edu/?page_id=340 |
| 346 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 347 | 26192398 https://www.ncbi.nlm.nih.gov/pubmed/26192398 |
| 348 | Characteristics and Outcomes of Eligible Nonenrolled Patients in a Mechanical Ventilation Trial of Acute Respiratory Distress Syndrome. https://ctgate.cci.fsu.edu/?page_id=341 |
| 349 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 350 | 26283667 https://www.ncbi.nlm.nih.gov/pubmed/26283667 |
| 351 | Exploring threats to generalisability in a large international rehabilitation trial (AVERT). https://ctgate.cci.fsu.edu/?page_id=342 |
| 352 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 353 | 26330533 https://www.ncbi.nlm.nih.gov/pubmed/26330533 |
| 354 | Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice. https://ctgate.cci.fsu.edu/?page_id=343 |
| 355 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 356 | 26362666 https://www.ncbi.nlm.nih.gov/pubmed/26362666 |
| 357 | External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA. https://ctgate.cci.fsu.edu/?page_id=344 |
| 358 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 359 | 26562046 https://www.ncbi.nlm.nih.gov/pubmed/26562046 |
| 360 | Generalizability of SPRINT Results to the U.S. Adult Population. https://ctgate.cci.fsu.edu/?page_id=345 |
| 361 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 362 | 26743093 https://www.ncbi.nlm.nih.gov/pubmed/26743093 |
| 363 | How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World? https://ctgate.cci.fsu.edu/?page_id=346 |
| 364 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 365 | 26820188 https://www.ncbi.nlm.nih.gov/pubmed/26820188 |
| 366 | Multivariate analysis of the population representativeness of related clinical studies. https://ctgate.cci.fsu.edu/?page_id=347 |
| 367 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 368 | 26825855 https://www.ncbi.nlm.nih.gov/pubmed/26825855 |
| 369 | Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network. https://ctgate.cci.fsu.edu/?page_id=348 |
| 370 | Standardized mean difference (SSMD) of propensity scores https://ctgate.cci.fsu.edu/tutorial-ssmd-of-propensity-scores/ |
| 371 | 27033859 https://www.ncbi.nlm.nih.gov/pubmed/27033859 |
| 372 | External validity of the "all-comers" design: insights from the BIOSCIENCE trial. https://ctgate.cci.fsu.edu/?page_id=349 |
| 373 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 374 | 27104965 https://www.ncbi.nlm.nih.gov/pubmed/27104965 |
| 375 | Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validity. https://ctgate.cci.fsu.edu/?page_id=350 |
| 376 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 377 | 27109827 https://www.ncbi.nlm.nih.gov/pubmed/27109827 |
| 378 | Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden. https://ctgate.cci.fsu.edu/?page_id=351 |
| 379 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 380 | 27283295 https://www.ncbi.nlm.nih.gov/pubmed/27283295 |
| 381 | Baseline Characteristics and Generalizability of Participants in an Internet Smoking Cessation Randomized Trial. https://ctgate.cci.fsu.edu/?page_id=352 |
| 382 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 383 | 27520290 https://www.ncbi.nlm.nih.gov/pubmed/27520290 |
| 384 | Older patients are still under-represented in clinical trials of Alzheimer's disease. https://ctgate.cci.fsu.edu/?page_id=353 |
| 385 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 386 | 27598694 https://www.ncbi.nlm.nih.gov/pubmed/27598694 |
| 387 | Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials. https://ctgate.cci.fsu.edu/?page_id=354 |
| 388 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 389 | 27600407 https://www.ncbi.nlm.nih.gov/pubmed/27600407 |
| 390 | GIST 2.0: A scalable multi-trait metric for quantifying population representativeness of individual clinical studies. https://ctgate.cci.fsu.edu/?page_id=355 |
| 391 | GIST 2.0 https://ctgate.cci.fsu.edu/tutorial-gist-2-0/ |
| 392 | 27753599 https://www.ncbi.nlm.nih.gov/pubmed/27753599 |
| 393 | External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation. https://ctgate.cci.fsu.edu/?page_id=356 |
| 394 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 395 | 27863344 https://www.ncbi.nlm.nih.gov/pubmed/27863344 |
| 396 | Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline. https://ctgate.cci.fsu.edu/?page_id=357 |
| 397 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 398 | 27638094 https://www.ncbi.nlm.nih.gov/pubmed/27638094 |
| 399 | Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer. https://ctgate.cci.fsu.edu/?page_id=358 |
| 400 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 401 | 27779514 https://www.ncbi.nlm.nih.gov/pubmed/27779514 |
| 402 | Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study. https://ctgate.cci.fsu.edu/?page_id=359 |
| 403 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 404 | 27984524 https://www.ncbi.nlm.nih.gov/pubmed/27984524 |
| 405 | Investigating generalizability of results from a randomized controlled trial of the management of chronic widespread pain: the MUSICIAN study. https://ctgate.cci.fsu.edu/?page_id=360 |
| 406 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 407 | 28028598 https://www.ncbi.nlm.nih.gov/pubmed/28028598 |
| 408 | A comparison of the MOMS trial results to a contemporaneous, single-institution, postnatal closure cohort. https://ctgate.cci.fsu.edu/?page_id=361 |
| 409 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 410 | 28118923 https://www.ncbi.nlm.nih.gov/pubmed/28118923 |
| 411 | Computer-aided assessment of the generalizability of clinical trial results. https://ctgate.cci.fsu.edu/?page_id=362 |
| 412 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 413 | 28125858 https://www.ncbi.nlm.nih.gov/pubmed/28125858 |
| 414 | Generalizability analysis for clinical trials: a simulation study. https://ctgate.cci.fsu.edu/?page_id=363 |
| 415 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 416 | 28191694 https://www.ncbi.nlm.nih.gov/pubmed/28191694 |
| 417 | Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network. https://ctgate.cci.fsu.edu/?page_id=364 |
| 418 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 419 | 28230450 https://www.ncbi.nlm.nih.gov/pubmed/28230450 |
| 420 | Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials. https://ctgate.cci.fsu.edu/?page_id=365 |
| 421 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 422 | 28434933 https://www.ncbi.nlm.nih.gov/pubmed/28434933 |
| 423 | Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings. https://ctgate.cci.fsu.edu/?page_id=366 |
| 424 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 425 | 28511033 https://www.ncbi.nlm.nih.gov/pubmed/28511033 |
| 426 | Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. https://ctgate.cci.fsu.edu/?page_id=367 |
| 427 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 428 | 28722466 https://www.ncbi.nlm.nih.gov/pubmed/28722466 |
| 429 | Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. https://ctgate.cci.fsu.edu/?page_id=368 |
| 430 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 431 | 28763313 https://www.ncbi.nlm.nih.gov/pubmed/28763313 |
| 432 | Generalizability of EXCEL and NOBLE results to a large registry population with unprotected left main coronary artery disease. https://ctgate.cci.fsu.edu/?page_id=369 |
| 433 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 434 | 28972695 https://www.ncbi.nlm.nih.gov/pubmed/28972695 |
| 435 | Testing the external validity of EORTC 30904 comparing overall survival after radical nephrectomy vs nephron sparing surgery in contemporary North American patients with renal cell cancer. https://ctgate.cci.fsu.edu/?page_id=370 |
| 436 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 437 | 29025047 https://www.ncbi.nlm.nih.gov/pubmed/29025047 |
| 438 | The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0. https://ctgate.cci.fsu.edu/?page_id=371 |
| 439 | GIST 2.0 https://ctgate.cci.fsu.edu/tutorial-gist-2-0/ |
| 440 | 29153885 https://www.ncbi.nlm.nih.gov/pubmed/29153885 |
| 441 | Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions. https://ctgate.cci.fsu.edu/?page_id=372 |
| 442 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 443 | 29230192 https://www.ncbi.nlm.nih.gov/pubmed/29230192 |
| 444 | External Validity of Randomized Controlled Trials on Alzheimer's Disease: The Biases of Frailty and Biological Aging. https://ctgate.cci.fsu.edu/?page_id=373 |
| 445 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 446 | 29241487 https://www.ncbi.nlm.nih.gov/pubmed/29241487 |
| 447 | Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes. https://ctgate.cci.fsu.edu/?page_id=374 |
| 448 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 449 | 28963367 https://www.ncbi.nlm.nih.gov/pubmed/28963367 |
| 450 | TREVO stent-retriever mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion registry. https://ctgate.cci.fsu.edu/?page_id=375 |
| 451 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorials/NHANES_T2D.html |
| 452 | 29020193 https://www.ncbi.nlm.nih.gov/pubmed/29020193 |
| 453 | Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population. https://ctgate.cci.fsu.edu/?page_id=376 |
| 454 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 455 | 29097339 https://www.ncbi.nlm.nih.gov/pubmed/29097339 |
| 456 | Comparable outcomes among trial and nontrial participants in a clinical trial of antibiotics for childhood pneumonia: a retrospective cohort study. https://ctgate.cci.fsu.edu/?page_id=377 |
| 457 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 458 | 29288137 https://www.ncbi.nlm.nih.gov/pubmed/29288137 |
| 459 | A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial https://ctgate.cci.fsu.edu/?page_id=378 |
| 460 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 461 | 29426695 https://www.ncbi.nlm.nih.gov/pubmed/29426695 |
| 462 | Only https://ctgate.cci.fsu.edu/?page_id=379 |
| 463 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorials/NHANES_T2D.html |
| 464 | 29464791 https://www.ncbi.nlm.nih.gov/pubmed/29464791 |
| 465 | Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta‐analytic studies https://ctgate.cci.fsu.edu/?page_id=380 |
| 466 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 467 | 29569403 https://www.ncbi.nlm.nih.gov/pubmed/29569403 |
| 468 | Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention. https://ctgate.cci.fsu.edu/?page_id=381 |
| 469 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 470 | 29569403 https://www.ncbi.nlm.nih.gov/pubmed/29569403 |
| 471 | Generalizability of the findings from a randomized controlled trial of a web-based substance use disorder intervention. https://ctgate.cci.fsu.edu/?page_id=382 |
| 472 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 473 | 29693361 https://www.ncbi.nlm.nih.gov/pubmed/29693361 |
| 474 | Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population. https://ctgate.cci.fsu.edu/?page_id=383 |
| 475 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 476 | 29701877 https://www.ncbi.nlm.nih.gov/pubmed/29701877 |
| 477 | Nutrition Therapy in Australia and New Zealand Intensive Care Units: An International Comparison Study. https://ctgate.cci.fsu.edu/?page_id=384 |
| 478 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 479 | 29884343 https://www.ncbi.nlm.nih.gov/pubmed/29884343 |
| 480 | An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States. https://ctgate.cci.fsu.edu/?page_id=385 |
| 481 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 482 | 29895587 https://www.ncbi.nlm.nih.gov/pubmed/29895587 |
| 483 | Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial. https://ctgate.cci.fsu.edu/?page_id=386 |
| 484 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 485 | 29944476 https://www.ncbi.nlm.nih.gov/pubmed/29944476 |
| 486 | Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomes https://ctgate.cci.fsu.edu/?page_id=387 |
| 487 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 488 | 30001984 https://www.ncbi.nlm.nih.gov/pubmed/30001984 |
| 489 | Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment https://ctgate.cci.fsu.edu/?page_id=388 |
| 490 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 491 | 30094623 https://www.ncbi.nlm.nih.gov/pubmed/30094623 |
| 492 | Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection. https://ctgate.cci.fsu.edu/?page_id=389 |
| 493 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 494 | 30189998 https://www.ncbi.nlm.nih.gov/pubmed/30189998 |
| 495 | Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus. https://ctgate.cci.fsu.edu/?page_id=390 |
| 496 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 497 | 30221183 https://www.ncbi.nlm.nih.gov/pubmed/30221183 |
| 498 | African American Screening and Enrollment in (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III) CLEAR III. https://ctgate.cci.fsu.edu/?page_id=391 |
| 499 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 500 | 30373488 https://www.ncbi.nlm.nih.gov/pubmed/30373488 |
| 501 | Representativeness of patients enrolled in a primary care clinical trial for heavy/problem substance use https://ctgate.cci.fsu.edu/?page_id=392 |
| 502 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 503 | 30415786 https://www.ncbi.nlm.nih.gov/pubmed/30415786 |
| 504 | Implementing statistical methods for generalizing randomized trial findings to a target population https://ctgate.cci.fsu.edu/?page_id=393 |
| 505 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 506 | 30466715 https://www.ncbi.nlm.nih.gov/pubmed/30466715 |
| 507 | Applicability of trials in rheumatoid arthritis and osteoarthritis: A systematic review and meta-analysis of trial populations showing adequate proportion of women, but underrepresentation of elderly people. https://ctgate.cci.fsu.edu/?page_id=394 |
| 508 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 509 | 30477321 https://www.ncbi.nlm.nih.gov/pubmed/30477321 |
| 510 | A data-zone scoring system to assess the generalizability of clinical trial results to individual patients. https://ctgate.cci.fsu.edu/?page_id=395 |
| 511 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 512 | 30555215 https://www.ncbi.nlm.nih.gov/pubmed/30555215 |
| 513 | Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights. https://ctgate.cci.fsu.edu/?page_id=396 |
| 514 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 515 | 30685675 https://www.ncbi.nlm.nih.gov/pubmed/30685675 |
| 516 | Generalizability of the FOURIER trial to routine clinical care: Do trial participants represent patients in everyday practice? https://ctgate.cci.fsu.edu/?page_id=397 |
| 517 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 518 | 30252687 https://www.ncbi.nlm.nih.gov/pubmed/30252687 |
| 519 | Diagnostic Assessment of Assumptions for External Validity: An Example Using Data in Metastatic Colorectal Cancer. https://ctgate.cci.fsu.edu/?page_id=398 |
| 520 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 521 | 30312378 https://www.ncbi.nlm.nih.gov/pubmed/30312378 |
| 522 | Comparison of Methods to Generalize Randomized Clinical Trial Results Without Individual-Level Data for the Target Population. https://ctgate.cci.fsu.edu/?page_id=399 |
| 523 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 524 | 30420256 https://www.ncbi.nlm.nih.gov/pubmed/30420256 |
| 525 | Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases. https://ctgate.cci.fsu.edu/?page_id=400 |
| 526 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 527 | 30673974 https://www.ncbi.nlm.nih.gov/pubmed/30673974 |
| 528 | Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics. https://ctgate.cci.fsu.edu/?page_id=401 |
| 529 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 530 | 30714309 https://www.ncbi.nlm.nih.gov/pubmed/30714309 |
| 531 | Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States. https://ctgate.cci.fsu.edu/?page_id=402 |
| 532 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 533 | 30746585 https://www.ncbi.nlm.nih.gov/pubmed/30746585 |
| 534 | Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria https://ctgate.cci.fsu.edu/?page_id=403 |
| 535 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 536 | 30819552 https://www.ncbi.nlm.nih.gov/pubmed/30819552 |
| 537 | Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease. https://ctgate.cci.fsu.edu/?page_id=404 |
| 538 | Comparing populations in clinical studies https://ctgate.cci.fsu.edu/tutorial-nhanes-t2d-and-ovarian-datasets/ |
| 539 | 30822358 https://www.ncbi.nlm.nih.gov/pubmed/30822358 |
| 540 | A Standardisation Approach to Compare Treatment Safety and Effectiveness Outcomes between Clinical Trials and Real World Populations in Psoriasis. https://ctgate.cci.fsu.edu/?page_id=405 |
| 541 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |
| 542 | 30846172 https://www.ncbi.nlm.nih.gov/pubmed/30846172 |
| 543 | Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual. https://ctgate.cci.fsu.edu/?page_id=406 |
| 544 | Propensity score weighting/matching https://ctgate.cci.fsu.edu/tutorial-propensity-score-weighting-matching/ |